Incidence of Myocarditis/Pericarditis Following mRNA COVID-19 Vaccination Among Children and Younger Adults in the United States.
作者信息
Goddard Kristin, Hanson Kayla E, Lewis Ned, Weintraub Eric, Fireman Bruce, Klein Nicola P
机构信息
Kaiser Permanente Vaccine Study Center, Kaiser Permanente Northern California, Oakland, California.
Marshfield Clinic Research Institute, Marshfield, Wisconsin.
出版信息
Ann Intern Med. 2022 Dec;175(12):1169-1771. doi: 10.7326/M22-2274. Epub 2022 Oct 4.
Abstract
摘要
相似文献
1
Incidence of Myocarditis/Pericarditis Following mRNA COVID-19 Vaccination Among Children and Younger Adults in the United States.
Ann Intern Med. 2022 Dec;175(12):1169-1771. doi: 10.7326/M22-2274. Epub 2022 Oct 4.
2
Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following covid-19 vaccination: living evidence syntheses and review.
BMJ. 2022 Jul 13;378:e069445. doi: 10.1136/bmj-2021-069445.
3
Epidemiology of Myocarditis and Pericarditis Following mRNA Vaccination by Vaccine Product, Schedule, and Interdose Interval Among Adolescents and Adults in Ontario, Canada.
JAMA Netw Open. 2022 Jun 1;5(6):e2218505. doi: 10.1001/jamanetworkopen.2022.18505.
4
Pericarditis and myocarditis after COVID-19 mRNA vaccination in a nationwide setting.
Ann Acad Med Singap. 2022 Feb;51(2):96-100. doi: 10.47102/annals-acadmedsg.2021425.
5
Myocarditis and pericarditis risk with mRNA COVID-19 vaccination compared to unvaccinated individuals: A retrospective cohort study in a Spanish Tertiary Hospital.
Biomed Pharmacother. 2024 Feb;171:116181. doi: 10.1016/j.biopha.2024.116181. Epub 2024 Jan 22.
6
Reports of myocarditis and pericarditis following mRNA COVID-19 vaccination: a systematic review of spontaneously reported data from the UK, Europe and the USA and of the scientific literature.
BMJ Open. 2022 May 25;12(5):e059223. doi: 10.1136/bmjopen-2021-059223.
7
Myocarditis and/or pericarditis risk after mRNA COVID-19 vaccination: A Canadian head to head comparison of BNT162b2 and mRNA-1273 vaccines.
Vaccine. 2022 Jul 30;40(32):4663-4671. doi: 10.1016/j.vaccine.2022.05.048. Epub 2022 May 25.
8
Myocarditis and pericarditis following mRNA COVID-19 vaccination in younger patients: is there a shared thread?
Expert Rev Cardiovasc Ther. 2022 Feb;20(2):87-90. doi: 10.1080/14779072.2022.2044305. Epub 2022 Feb 25.
9
Postmarketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12 to 39 years in Italy: A multi-database, self-controlled case series study.
PLoS Med. 2022 Jul 28;19(7):e1004056. doi: 10.1371/journal.pmed.1004056. eCollection 2022 Jul.
10
Assessing the temporal and cause-effect relationship between myocarditis and mRNA COVID-19 vaccines. A retrospective observational study.
Int J Infect Dis. 2024 Apr;141:106960. doi: 10.1016/j.ijid.2024.02.003. Epub 2024 Feb 14.
引用本文的文献
1
Cost-Effectiveness of 2023-2024 COVID-19 Vaccination in US Adults.
JAMA Netw Open. 2025 Aug 1;8(8):e2523688. doi: 10.1001/jamanetworkopen.2025.23688.
2
The New Era of mRNA Vaccines: The Success of the COVID-19 Vaccines and the Safety Concerns in Adolescents.
Indian J Community Med. 2025 May-Jun;50(3):404-406. doi: 10.4103/ijcm.ijcm_544_23. Epub 2024 Nov 13.
3
Mechanistic insights into COVID-19 mRNA vaccine-associated myocarditis: a bioinformatics analysis.
Am J Transl Res. 2025 Mar 15;17(3):2339-2351. doi: 10.62347/CCVM6311. eCollection 2025.
4
Vaccination Strategies in Respiratory Diseases: Recommendation from AIPO-ITS/ETS, SIMIT, SIP/IRS, and SItI.
Respiration. 2025;104(8):556-574. doi: 10.1159/000544919. Epub 2025 Mar 9.
5
Biomarkers of vaccine safety and efficacy in vulnerable populations: Lessons from the fourth international precision vaccines conference.
Vaccine. 2025 Jan 1;43(Pt 2):126477. doi: 10.1016/j.vaccine.2024.126477. Epub 2024 Nov 28.
6
Myocarditis and Pericarditis are Temporally Associated with BNT162b2 COVID-19 Vaccine in Adolescents: A Systematic Review and Meta-analysis.
Pediatr Cardiol. 2024 Oct 15. doi: 10.1007/s00246-024-03618-2.
7
COVID-19 immunization status in children compared to their parents: a retrospective review at an upstate NY medicine/pediatrics practice.
BMC Pediatr. 2024 Sep 6;24(1):570. doi: 10.1186/s12887-024-05039-9.
8
Uptake and cardiac events of COVID-19 vaccinations among Canadian youth and young adults.
PLOS Glob Public Health. 2024 Jul 31;4(7):e0003363. doi: 10.1371/journal.pgph.0003363. eCollection 2024.
9
Safety outcomes following COVID-19 vaccination and infection in 5.1 million children in England.
Nat Commun. 2024 May 27;15(1):3822. doi: 10.1038/s41467-024-47745-z.
10
Current Progress, Challenges and Prospects in the Development of COVID-19 Vaccines.
Drugs. 2024 Apr;84(4):403-423. doi: 10.1007/s40265-024-02013-8. Epub 2024 Apr 23.
Zotero 插件